Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

作者: Steffi Oesterreich , Edward M. Curran , C. Kent Osborne , Adrian V. Lee , Rebecca L. Guler

DOI:

关键词:

摘要: Estrogen can increase insulin-like growth factor-I receptor (IGF-IR) and insulin substrate-1 (IRS-1) expression, two key components of IGF-I-mediated signaling. The result is sensitization breast cancer cells to IGF-I synergistic in the presence estrogen IGF-I. We hypothesized that loss alpha (ERalpha) would reduced IGF-mediated signaling growth. To test this hypothesis, we examined effects MCF-7 cell sublines have been selected for ERalpha (C4 C4-12 are ERalpha-negative) by long-term withdrawal. C4 had IGF-IR IRS-1 mRNA protein expression (compared with cells) was not inducible estrogen. Furthermore, showed failed show any response either or prove IGF estrogen-mediated a consequence ERalpha, re-expressed stable transfection HA-tagged ERalpha. Three independent ERalpha-HA clones expressed functional (a) down-regulated estrogen, (b) conferred estrogen-induction cyclin D1 (c) caused number S phase. All were completely blocked antiestrogens. Interestingly, did restore induction progesterone expression. However, ERalpha-positive now exhibited levels responded mitogenically both These data critical requirement signaling, our knowledge first report confers an ER-negative line.

参考文章(59)
Marina A. Guvakova, Ewa Surmacz, Tamoxifen Interferes with the Insulin-like Growth Factor I Receptor (IGF-IR) Signaling Pathway in Breast Cancer Cells Cancer Research. ,vol. 57, pp. 2606- 2610 ,(1997)
Timothy J. Triche, Katherine Seibert, Jeffrey H. Toney, Karen K. Huff, Samir M. Shafie, Marc E. Lippman, Stephen J. O'Brien, Jacqueline J. Whang-Peng, Clonal Variation of MCF-7 Breast Cancer Cells In Vitro and in Athymic Nude Mice Cancer Research. ,vol. 43, pp. 2223- 2239 ,(1983)
Wayne P. Bocchinfuso, Kenneth S. Korach, Mammary gland development and tumorigenesis in estrogen receptor knockout mice. Journal of Mammary Gland Biology and Neoplasia. ,vol. 2, pp. 323- 334 ,(1997) , 10.1023/A:1026339111278
Michele M. Toenniges, Pamela J. Berlinski, W. Barkley Butler, William H. Kelsey, Roberta M. Hillman, Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Research. ,vol. 46, pp. 6339- 6348 ,(1986)
Douglas Yee, Adrian V. Lee, Crosstalk between the insulin-like growth factors and estrogens in breast cancer. Journal of Mammary Gland Biology and Neoplasia. ,vol. 5, pp. 107- 115 ,(2000) , 10.1023/A:1009575518338
H Watada, Y Yamasaki, T Morishima, N Iwama, Y Kajimoto, E Imano, Y Umayahara, T Kamada, R Kawamori, Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. Journal of Biological Chemistry. ,vol. 269, pp. 16433- 16442 ,(1994) , 10.1016/S0021-9258(17)34025-5
Sebastiano Ando, Loredana Mauro, Catia Morelli, Eva Surmacz, Monica Bartucci, Differential Insulin-like Growth Factor I Receptor Signaling and Function in Estrogen Receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 Breast Cancer Cells Cancer Research. ,vol. 61, pp. 6747- 6754 ,(2001)
M. Garcia, D. Derocq, G. Freiss, H. Rochefort, Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 11538- 11542 ,(1992) , 10.1073/PNAS.89.23.11538